~~<i id='E12E6BF1F2'><strike id='E12E6BF1F2'><tt id='E12E6BF1F2'><pre id='E12E6BF1F2'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

knowledge

author：explore 2025-09-04 22:17:04 - browse：6547

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Why sickle cell disease is getting the first CRISPR treatment

knowledge

explore

knowledge

explore

AprotesterstandsoutsidetheSupremeCourtinWashingtoninApril2023.ShuranHuang/TheNewYorkTimesWASHINGTON—

WSS

Americans' trust in science, scientist continues decline: Report

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Ransomware attacks on hospitals: Study outlines patient impact

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

explore

knowledge

knowledge

The cancer drug shortage isn’t new — and neither are the solutions

Astellas still sees hope in its gene therapy after four deaths

State Dept. review finds Biden bears some blame for Afghanistan failures

Gain of function research would be limited under House proposal

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Chemotherapy shortages won’t get better under Biden’s latest plan

What does generative AI mean for health care? We asked experts

In diabetes hearing, Sanders takes on a new foe: food makers

Affirmative action in medical school literally saved lives

Pharma patents targeted by Biden in move to slash drug prices

knowledge

CRISPR pioneers react to Casgevy, first gene

In key trial, Verve's treatment lowers cholesterol levels in patients

Anthos stroke drug appears safer than common blood thinner

NYU radiologists take on the challenge of expensive MRI machines

Americans' trust in science, scientist continues decline: Report

CRISPR pioneers react to Casgevy, first gene

knowledge

explore

knowledge

explore